Source: Eur Respir J 2001; 18: 1077



Rating:

Share or cite this content

Citations should be made in the following way:
Teramoto S., Kume H., Matsuse T., Ishii T., Inoue Y.. Angiotensin converting enzyme in patients with sleep apnoea syndrome: plasma activity and gene polymorphisms. Eur Respir J 2001; 18: 1077

Member's Comments

No comment yet.

Related content which might interest you: Angiotensin converting enzyme in patients with sleep apnoea syndrome: plasma activity and gene polymorphisms Source: Eur Respir J 2001; 17: 728-732 Year: 2001 The association of angiotensin-converting enzyme gene insertion/deletion polymorphisms with OSA: a meta-analysis Source: Eur Respir J 2012; 40: 394-399 Year: 2012 Effect of angiotensin converting enzyme (ACE) gene polymorphism on diaphragmatic endurance in neonates Source: Annual Congress 2008 - Neonatal intensive care: ventilation and beyond Year: 2008 Association of serotonin transporter gene polymorphism with obstructive sleep apnea syndrome Source: Eur Respir J 2005; 26: Suppl. 49, 357s Year: 2005 Association of circulating angiotensin converting enzyme activity with respiratory muscle function in infants Source: Annual Congress 2010 - Paediatric and neonatal intensive care Year: 2010 Etiology specific reductions in pulmonary endothelial angiotensin converting enzyme activity in patients with PAH Source: Eur Respir J 2006; 28: Suppl. 50, 658s Year: 2006 ACE I/D but not AGT (-6)A/G polymorphism is a risk factor for mortality in ARDS Source: Eur Respir J 2007; 29: 482-488 Year: 2007 Correlation between angiotensin-converting enzyme (ACE) gene polymorphism and exercise performance in COPD patients Source: Annual Congress 2010 - Exercise in COPD Year: 2010 Role of angiotensin receptors in the preclinical cardiovascular risk in obstructive sleep apnea patients Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases Year: 2017 Association of NADPH oxidase polymorphisms with obstructive sleep apnoea syndrome Source: Annual Congress 2009 - Pathogenesis of sleep-disordered breathing Year: 2009 Frequency of distribution of IL-1, IL-6 and TNFa gene polymorphism in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2006 - Metabolic control in obstructive sleep apnoea Year: 2006 Association of IL-6 and TNFα and leptin receptor (LEPR) gene polymorphism with IL-6 and TNFα serum level in obstructive sleep apnea syndrome (OSAS) patients Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007 Increased angiotensin II (Ang II) and oxidants are critical for angiogenesis and endothelial receptor for oxidized LDL (LOX-1) expression in obstructive sleep apnea (OSA) patients Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007 Association of GABABR1 receptor gene polymorphism with obstructive sleep apnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 642s Year: 2006 Renin and aldosterone levels in obstructive sleep apnea syndrome patients Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing Year: 2015 Clock gene dysfunction in patients with obstructive sleep apnoea syndrome Source: Eur Respir J 2008; 32: 105-112 Year: 2008 Polymorphisms in angiotensin converting enzyme gene are associated with risk of development of and disease severity in scleroderma-related pulmonary arterial hypertension Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms Year: 2012 Urinary biomarkers for obstructive sleep apnea syndrome: Lipocalin type prostaglandin-D synthase and F2-isoprostane Source: International Congress 2018 – Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality Year: 2018 Angio-inhibitory activity and decreased leptin level in sera from obstructive sleep apnea syndrome (OSAS) patients Source: Eur Respir J 2001; 18: Suppl. 33, 334s Year: 2001 No association of angiotensin I-converting enzyme gene polymorphism and pulmonary function in cystic fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 173s Year: 2003